Related references
Note: Only part of the references are listed.Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease
E. T. Waas et al.
EJSO (2006)
Molecular prognostic markers in resectable colorectal liver metastases: A systematic review
C. P. Neal et al.
EUROPEAN JOURNAL OF CANCER (2006)
Biology of colorectal liver metastases: A review
Nigel C. Bird et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
Observer variation in immunohistochemical analysis of protein expression, time for a change?
T. Kirkegaard et al.
HISTOPATHOLOGY (2006)
Molecular mechanisms of hepatic metastasis in colorectal cancer
LR Rudmik et al.
JOURNAL OF SURGICAL ONCOLOGY (2005)
Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer
CJ Witton et al.
HISTOPATHOLOGY (2004)
Estimating the generalized concordance correlation coefficient through variance components
JL Carrasco et al.
BIOMETRICS (2003)
Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines
MJ Duffy et al.
EUROPEAN JOURNAL OF CANCER (2003)
Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy
HF Dvorak
JOURNAL OF CLINICAL ONCOLOGY (2002)
Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis
A Pozzi et al.
ONCOGENE (2002)
Expression of matrix metalloproteinase-1 in human colorectal carcinoma
J Shiozawa et al.
MODERN PATHOLOGY (2000)
Share Paper
